Stratasys ( SSYS Quick Quote SSYS - Free Report) recently launched its new compact multi-material dental 3D printer — J5 DentaJet — to eliminate the time-consuming process of producing dental parts. Notably, dental labs face the challenge of producing different parts of a dental set in different materials, forcing them to make separate 3D prints using different materials for different parts of the set. The J5 DentaJet can print with up to five materials, including support material. Moreover, it can produce five times more dental parts on a single mixed tray at a much lesser time than any other 3D printer, occupying only 4.6 sq. ft. of floor space.
Furthermore, 3D prints of realistic case presentations can be created with the J5 DentaJet. The high resolution of PolyJet materials allows dentists to implant crowns and bridges more quickly due to the accuracy of the models.
Stratasys’ Healthcare Vice President, Osnat Philipp said, “Dental and orthodontic models have been growing their adoption of 3D printing but the process has remained too manual and time consuming. The J5 DentaJet advances the full digital transformation of dental modeling with the potent combination of automation with accuracy. The system runs largely unattended, and you can even produce a build tray with a wide variety of different models using several different materials.” Philipp also went on to call the printer a “productivity monster”. The J5 DentaJet has been under beta testing by a couple of orthodontic labs, which have given positive reviews. Stratasys estimates the total addressable segment for dental 3D printing at about $1 billion. Per MarketsandMarkets, the dental 3D printing market is expected to reach $6.5 billion by 2025 from $1.8 billion in 2020, at a CAGR of 28.8%. The bright prospects of the dental 3D printing space are attracting tough competition from 3D printing stalwarts like HP HPQ, 3D Systems ( DDD Quick Quote DDD - Free Report) and Voxeljet VJET. Nonetheless, with the recent buyout of Origin, Stratasys gains a competitive edge in the 3D-printed mass production parts market with the integration of the former’s software-centric additive manufacturing solution. Moreover, Origin’s manufacturing-grade 3D printer, which uses its proprietary resin-based Programmable PhotoPolymerization (P3) technology, is expected to enable Stratasys to deliver polymer-based additive systems to dental, medical, tooling and other industries, generating incremental annual revenues of $200 million within five years. Stratasys currently carries a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>